Status:
ACTIVE_NOT_RECRUITING
Efficacy of Intracavernous Platelet-rich Plasma Injection in the Treatment of Erectile Dysfunction
Lead Sponsor:
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Collaborating Sponsors:
t-biyoteknoloji labaratuvar estetik medikal kozmetik san. ve tic. ltd. şti.
Conditions:
Erectile Dysfunction
Eligibility:
MALE
40-70 years
Phase:
PHASE3
Brief Summary
Investigation of the efficacy of autologous platelet-rich plasma administration on the potency of patients with vasculogenic and/or neurogenic erectile dysfunction
Eligibility Criteria
Inclusion
- \- 1)40-70 years old male, sexually active heterosexual, 2) Patients with a diagnosis of mild to moderate erectile dysfunction (IIEF score between 8-21) according to the International Index of Erectile Function (IIEF) for at least 3 months, 3) Patients who cannot achieve an erection despite peroral PDE5 inhibitor and intracavernous alprostadil injection therapy
Exclusion
- Patients with psychogenic erectile dysfunction, 2) Patients with a history of priapism, penile fracture, peyronie, penile curvature 3) Patients with a history of radical prostatectomy, 4) Patients with a history of major pelvic trauma, surgery, radiotherapy, 5) Patients with a history of malignancy affecting survival, 6) Patients with severe psychiatric illness that impairs adherence to treatment, 7) Patients with any bleeding disorder or on anti-aggregants/coagulants.
Key Trial Info
Start Date :
December 29 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2025
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06942988
Start Date
December 29 2023
End Date
July 29 2025
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences, Bakırköy Sadi Konuk Training and Research Hospital
Istanbul, Istanbul, Turkey (Türkiye), 34147